$2.62
-0.08-2.96%
Last update: Nov 5, 9:36 AM
Eledon Pharmaceuticals Inc
ELDNNASDAQ
The average analyst price target for Eledon Pharmaceuticals is $11.40, 335.1% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $8 to $16. The latest change came on Jul 21, 2026, when Rodman & Renshaw initiated coverage of Eledon Pharmaceuticals with a Buy rating and a $12 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
